<DOC>
	<DOCNO>NCT00204464</DOCNO>
	<brief_summary>Amyotrophic Lateral Sclerosis ( ALS ) common motor neuron disease MND ) among adult . Motor neuron spinal cord , brain stem , cerebral motor cortex degenerate create variety upper ( UMN ) low motor neuron ( LMN ) clinical sign symptom , frequently present symptom focal weakness begin leg , arm , bulbar muscle , occur 70 % patient . Despite high incidence muscle weakness patient ALS , two case study evaluate effect specific muscle strengthen endurance exercise program patient population publish , effect resistive exercise program patient ALS well study . Some discourage exercise program patient ALS fear overuse weakness . Yet , patient neuromuscular disease , resistive exercise program show beneficial produce overuse weakness . The purpose study determine effect six month strengthen program strength , function , fatigue quality life individual ALS .</brief_summary>
	<brief_title>Study Effects Strengthening Exercises Individuals With ALS</brief_title>
	<detailed_description>The specific aim preliminary , prospective randomize study individual ALS determine variability , describe trend 6-month time frame estimate difference individual ALS perform upper low extremity strengthen program three time per week control group individual ALS respect follow outcome : 1. increase muscle strength ( maximum voluntary isometric contraction ) measure quantitative muscle test . 2. increase functional activity measure The Amyotrophic Lateral Sclerosis Functional Rating Scale ( ALSFRS ) 7 Schwab England Rating Scale ( SERS ) . 3. decrease fatigue measure Fatigue Severity Scale . 4. increase quality life measure SF-36.Subjects randomize two group - experimental control . Subjects control group perform daily stretch exercise program period six month . Subjects experimental group perform strengthen exercise program three time per week period six month . All subject evaluate baseline monthly use follow outcome measure : ( 1 ) maximum voluntary isometric contraction ; ( 2 ) Amyotrophic Lateral Sclerosis Functional Rating Scale ; ( 3 ) Schwab England Rating Scale ; ( 3 ) Fatigue Severity Scale ; ( 4 ) force vital capacity ; , ( 5 ) SF-36 .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>definite and/or probable diagnosis ALS early stage disease history neuromuscular dysfunction relate ALS active , confound medical condition unwillingness inability comply protocol FVC le 90 % predict ALSFRS score less 30</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Exercise</keyword>
</DOC>